The utility of scoring systems in predicting early and late mortality in alcoholic hepatitis: whose score is it anyway?
- PMID: 22988517
- PMCID: PMC3440866
- DOI: 10.1155/2012/624675
The utility of scoring systems in predicting early and late mortality in alcoholic hepatitis: whose score is it anyway?
Abstract
Background. Alcoholic hepatitis (AH) is a distinct clinical entity in the spectrum of alcoholic liver disease with a high short-term mortality. Several scoring systems are being used to assess the severity of AH but the ability of these scores to predict long-term survival in these patients is largely unknown. Aims. We aim to assess the utility of five different scoring systems Child Pugh (CP), model for end-stage liver disease (MELD), Maddrey's discriminant function (mDF), Glasgow AH score (GAHS), and age-bilirubin-INR-creatinine (ABIC) score in predicting shot-term and long-term survival in patients with AH. Methods. Patients with histological evidence of AH were identified from our database. The clinical and biochemical parameters were used to calculate the 5 different scores. The prognostic utility of these scores was determined by generating an ROC curve for survival at 30 days, 90 days, 6 months, and 1 year. Results and Conclusions. All 5 scores with the exception of CP score have a similar accuracy in predicting the short-term prognosis. However, they are uniformly poor in predicting longer-term survival with AUROC not exceeding 0.74. CP score is a very poor predictor of survival in both short and long term. Abstinence from alcohol was significantly (P < 0.05) associated with survival at 1 year.
References
-
- Aithal GP. Defining “acute on chronic liver failure”: an identity crisis! Indian Journal of Gastroenterology. 2010;29(5):177–180. - PubMed
-
- MacSween RNM, Burt AD. Histologic spectrum of alcoholic liver disease. Seminars in Liver Disease. 1986;6(3):221–232. - PubMed
-
- Sandahl TD, Jepsen P, Thomsen KL, Vilstrup H. Incidence and mortality of alcoholic hepatitis in Denmark 1999–2008: a nationwide population based cohort study. Journal of Hepatology. 2011;54(4):760–764. - PubMed
-
- Fleming KM, Aithal GP, Card TR, West J. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Alimentary Pharmacology and Therapeutics. 2010;32(11-12):1343–1350. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous